(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More
(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks. Read More
(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains for pharmaceuticals as GSK shook off Zantac litigation. Read More
(Alliance News) - Stocks in London were set to start flat on Wednesday, as weak economic data from China pointed to a "deep malaise" in the global economy, though this was offset by news that Asia's largest economy will loosen its strict zero-Covid measures. Read More
(Alliance News) - Stocks in London were mixed at the open on Friday ahead of the release of a key gauge of US economic health, the non-farm payrolls report, which many expect to influence the size of the Federal Reserve's next interest rate hike at its next meeting this month. Read More
(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted a marketing authorisation application for momelotinib, its treatment for myelofibrosis, a rare bone marrow cancer. Additionally, it announced positive results from a trial investigating Jemperli. Read More
(Alliance News) - Stocks in London are set to open marginally lower on Friday, ahead of US non-farm payrolls later in the day, a piece of data expected to loom large for the US Federal Reserve at its December meeting. Read More
(Alliance News) - London's FTSE 100 index was outperforming on Tuesday morning as a rising Brent price lifted its heavyweight oil stocks, while other equities were shaken by further Covid measures in China. Read More
(Alliance News) - GSK PLC on Tuesday said it has started the process to withdraw US marketing authorisation for its cancer drug, Blenrep, on the request of the US Food & Drug Administration. Read More
(Alliance News) - Stocks in London were called slightly higher on Tuesday, as a rising Brent oil price supported the FTSE 100 index, despite unease over Covid-related developments in China. Read More
(Alliance News) - Equities in Europe were celebrating a cooler-than-expected US CPI print on Thursday, which gave rise to hopes that peak inflation in the US has passed. Read More
